Picture of Cencora logo

COR — Cencora Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareConservativeLarge CapNeutral

Annual cashflow statement for Cencora, fiscal year end - September 30th, USD millions except per share, conversion factor applied.

2022
September 30th
2023
September 30th
2024
September 30th
2025
September 30th
2026
September 30th
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-KPRESS
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalPreliminary
Net Income/Starting Line1,6671,7331,5191,5683,501
Depreciation
Amortisation
Deferred Taxes
Non-Cash Items2704426501,144—
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital-14087529935.41,269
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Taxes Payable
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities2,7023,9113,4853,8754,771
Capital Expenditures-496-458-487-668-910
Purchase of Fixed Assets
Other Investing Cash Flow Items128-2,144-131-4,309-4,891
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-368-2,602-618-4,977-5,801
Financing Cash Flow Items-48.2-80.7-75.8-103-118
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-1,753-2,222-2,3312,2491,653
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash523-8415451,097577